CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
the efficacy and safety of oral masitinib versus placebo in the treatment of patients with primary progressive or secondary progressive multiple...
Phase 3
Valencia, Spain and 36 other locations
This extension study will evaluate the effectiveness and safety of ocrelizumab in multiple sclerosis (MS) participants who...
Phase 3
Valencia, Spain and 161 other locations
To evaluate the safety and efficacy of fingolimod vs. interferon beta-1a i.m. in pediatric patients with multiple sclerosis (MS...
Phase 3
Valencia, Comunidad Valenciana, Spain and 107 other locations
study will compare ofatumumab vs. European approved platform first line self-administered disease modifying therapy (DMT) in newly diagnosed MS...
Phase 3
Valencia, Spain and 49 other locations
Open-label study to evaluate the effectiveness of treatment with ofatumumab in subjects transitioning from any fumarate-based RMS approved therapy or...
Phase 3
Valencia, Comunidad Valenciana, Spain and 122 other locations
To compare the efficacy and safety of remibrutinib versus teriflunomide in patients with relapsing multiple sclerosis (RMS)...
Phase 3
Valencia, Comunidad Valenciana, Spain and 208 other locations
To compare the efficacy and safety of remibrutinib versus teriflunomide in patients with relapsing multiple sclerosis (RMS)...
Phase 3
Valencia, Comunidad Valenciana, Spain and 225 other locations
The purpose of this study is to evaluate the safety, tolerability, efficacy, and drug levels of CC-97540 in participants with Relapsing Forms of Multiple...
Phase 1
València, Spain and 34 other locations
Bowel Care performed in a population of 92 subjects suffering from Multiple Sclerosis and confirmed Neurogenic Bowel Dysfunction. T...
Valencia, Spain and 4 other locations
This study is a prospective, multicenter, open-label, single-arm effectiveness and safety study in participants with progressive multiple sc...
Phase 3
Valencia, Spain and 125 other locations
Clinical trials
Research sites
Resources
Legal